A drug company in Great Britian wants to market a marijuana based medicine to treat multiple sclerosis and nervous system pain in the States.
GW Pharmaceuticals says it's accelerating plans to introduce cannabis-based medicines into the America. Sativex, is an under-the-tongue spray to treat the symptoms of multiple sclerosis and neuropathic pain.
The drug spray already won approval in Canada.
Google news search: GW Pharmaceuticals